Author： Hahl J.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.21, Iss.5, 2003-01, pp. : 295-303
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
High resource use and costs in type 1 diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 324, 2001-01 ,pp. :
Access to resources
Recommend
Vaccine Therapies for the Prevention of Type 1 Diabetes Mellitus
By Petrovsky N. Silva D. Schatz D.A.
Pediatric Drugs, Vol. 5, Iss. 9, 2003-01 ,pp. :
Emerging treatments for the prevention of type 1 diabetes
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. :
Prospects for the Prevention and Reversal of Type 1 Diabetes Mellitus
By Petrovsky N.
Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. :
Type 1 diabetes prevention trials: the debate rages on
Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. :